KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $22.3 billion.

  • Eli Lilly's Retained Earnings rose 6329.11% to $22.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $22.3 billion, marking a year-over-year increase of 6329.11%. This contributed to the annual value of $13.5 billion for FY2024, which is 3134.8% up from last year.
  • According to the latest figures from Q3 2025, Eli Lilly's Retained Earnings is $22.3 billion, which was up 6329.11% from $17.4 billion recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's Retained Earnings registered a high of $22.3 billion during Q3 2025, and its lowest value of $8.5 billion during Q2 2021.
  • For the 5-year period, Eli Lilly's Retained Earnings averaged around $11.8 billion, with its median value being $10.3 billion (2023).
  • In the last 5 years, Eli Lilly's Retained Earnings skyrocketed by 23333.48% in 2021 and then soared by 30.36% in 2022.
  • Eli Lilly's Retained Earnings (Quarter) stood at $9.0 billion in 2021, then increased by 12.1% to $10.0 billion in 2022, then grew by 2.69% to $10.3 billion in 2023, then surged by 31.35% to $13.5 billion in 2024, then surged by 64.28% to $22.3 billion in 2025.
  • Its last three reported values are $22.3 billion in Q3 2025, $17.4 billion for Q2 2025, and $15.1 billion during Q1 2025.